These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition. Janssen BJ; Halff EF; Lambris JD; Gros P J Biol Chem; 2007 Oct; 282(40):29241-7. PubMed ID: 17684013 [TBL] [Abstract][Full Text] [Related]
43. Evidence suggesting the occurrence of C3-independent intravascular immune hemolysis. Reactive hemolysis in vivo. Salama A; Bhakdi S; Mueller-Eckhardt C Transfusion; 1987; 27(1):49-53. PubMed ID: 3810824 [TBL] [Abstract][Full Text] [Related]
44. [Formation of classical C3 convertase during the alternative pathway of human complement activation]. Kozlov LV; Shibanova ED; Zinchenko AA Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798 [TBL] [Abstract][Full Text] [Related]
45. Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Salama A; Mueller-Eckhardt C Transfusion; 1984; 24(3):188-93. PubMed ID: 6610232 [TBL] [Abstract][Full Text] [Related]
51. Solution structure of Compstatin, a potent complement inhibitor. Morikis D; Assa-Munt N; Sahu A; Lambris JD Protein Sci; 1998 Mar; 7(3):619-27. PubMed ID: 9541394 [TBL] [Abstract][Full Text] [Related]
52. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333 [TBL] [Abstract][Full Text] [Related]
53. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688 [TBL] [Abstract][Full Text] [Related]
54. [Immunological damage to erythrocytes]. Engelfriet CP; von dem Borne AE; Fleer A; van der Meulen FW; Beckers D; van Treslong JP; Matthijse-Dekker A; Linthout-Goorhuis E Schweiz Med Wochenschr; 1976 Oct; 106(40):1330-6. PubMed ID: 1006250 [TBL] [Abstract][Full Text] [Related]
55. Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. Risitano AM; Perna F; Selleri C Mini Rev Med Chem; 2011 Jun; 11(6):528-35. PubMed ID: 21561403 [TBL] [Abstract][Full Text] [Related]
56. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway. Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572 [TBL] [Abstract][Full Text] [Related]
57. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3. Maekawa T; Briones RA; Resuello RR; Tuplano JV; Hajishengallis E; Kajikawa T; Koutsogiannaki S; Garcia CA; Ricklin D; Lambris JD; Hajishengallis G J Clin Periodontol; 2016 Mar; 43(3):238-49. PubMed ID: 26728318 [TBL] [Abstract][Full Text] [Related]
59. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20. Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J Front Immunol; 2020; 11():1643. PubMed ID: 32849563 [No Abstract] [Full Text] [Related]
60. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies. Risitano AM Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]